Ajanta Pharma Q1 FY27 results (Apr–Jun 2026) and concall

Healthcare · Concall AI · Call held 30 Jul 2026

Company page: Ajanta Pharma share price, financials & guidance record

Source transcript

Ajanta Pharma Limited Q1 FY27 Earnings Call Analysis

You’re reading a preview. Opening the full call uses 1 concall credit.

What they filed

Q1 FY27: revenue up 24.8%, net profit up 31.0% against the same quarter last year.

₹ Cr · quarterly

Line item	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue	1,187	1,146	1,170	1,303	1,354 +14%	1,375 +20%	1,422 +22%	1,626 +25%
Expenses	875	825	873	951	1,026	993	1,088	1,202
EBITDA	311	321	297	351	328 +5%	382 +19%	333 +12%	424 +21%
Margin	26%	28%	25%	27%	24%	28%	23%	26%
Other income	19	30	18	26	59	25	61	71
Interest	6	8	6	5	3	5	2	3
Depreciation	34	36	40	41	43	44	45	44
Profit before tax	290	307	269	331	341 +18%	359 +17%	347 +29%	447 +35%
Tax rate	25%	24%	16%	23%	24%	24%	23%	25%
Net profit	216	233	225	255	260 +20%	274 +18%	267 +19%	334 +31%
EPS	17.33	18.64	18.03	20.44	20.83	21.91	21.35	26.75

How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.

What they filed

More Healthcare earnings calls